SCHEMBL19649529

SCHEMBL19649529

C[C@@H]1[C@@H](C(=O)O)CC(C)(C)[C@@H]1C

nearest known ligand 0.39

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
APLNR P35414 1/20 0.39
GRM4 Q14833 4/20 0.37
CYP2C19 P33261 3/20 0.37
ALDH1A1 P00352 2/20 0.37
MEN1 O00255 1/20 0.37
CYP1A2 P05177 1/20 0.37
KMT2A Q03164 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
GRM8 O00222 1/20 0.37
GRM6 O15303 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C9 P11712 1/20 0.37
SLC6A12 P48065 1/20 0.32
SLC6A11 P48066 1/20 0.32
GABRR1 P24046 1/20 0.32
LMNA P02545 1/20 0.31
POLB P06746 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19638393 1.00 APLNR (0.39) APLNRGRM4CYP2C19ALDH1A1MEN1
SCHEMBL19651887 0.82 APLNR (0.30) APLNR
SCHEMBL19649536 0.78 GABRR1 (0.39) APLNRGRM4CYP2C19ALDH1A1MEN1
SCHEMBL19649538 0.77 ATM (0.34) ALDH1A1CYP1A2KMT2ACYP2D6
SCHEMBL19638369 0.77 ATM (0.34) ALDH1A1CYP1A2KMT2ACYP2D6
SCHEMBL28951980 0.70 EPHX1 (0.41) APLNR
SCHEMBL19638433 0.68 SLC6A12 (0.39) APLNRCYP2C19CYP1A2CYP2D6CYP2C9
SCHEMBL22345753 0.68 GRM4 (0.41) APLNRGRM4CYP2C19ALDH1A1MEN1
SCHEMBL7405779 0.68 SLC6A12 (0.41) APLNRGRM4CYP2C19ALDH1A1MEN1
SCHEMBL8522673 0.67 APLNR (0.62) APLNRGRM4CYP2C19ALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9919994-B2 Alpha-halotetramethycyclohexanone, a method for the preparation thereof, and a method for the preparation of a (2,3,4,4-tetramethylcyclopentyl)methy carboxylate compound SHIN-ETSU CHEMICAL CO., LTD. (JP) 2018-03-20 US disclosed
US-9919994-B2 Alpha-halotetramethycyclohexanone, a method for the preparation thereof, and a method for the preparation of a (2,3,4,4-tetramethylcyclopentyl)methy carboxylate compound SHIN-ETSU CHEMICAL CO., LTD. (JP) 2018-03-20 US disclosed
US-20170342013-A1 ALPHA-HALOTETRAMETHYCYCLOHEXANONE, A METHOD FOR THE PREPARATION THEREOF, AND A METHOD FOR THE PREPARATION OF A (2,3,4,4-TETRAMETHYLCYCLOPENTYL)METHY CARBOXYLATE COMPOUND SHIN-ETSU CHEMICAL CO., LTD. (JP) 2017-11-30 US disclosed
US-20170342013-A1 ALPHA-HALOTETRAMETHYCYCLOHEXANONE, A METHOD FOR THE PREPARATION THEREOF, AND A METHOD FOR THE PREPARATION OF A (2,3,4,4-TETRAMETHYLCYCLOPENTYL)METHY CARBOXYLATE COMPOUND SHIN-ETSU CHEMICAL CO., LTD. (JP) 2017-11-30 US disclosed
EP-3248959-A2 ALPHA HALOTETRAMETHYLCYCLOHEXANONE, A METHOD FOR THE PREPARATION THEREOF, AND A METHOD FOR THE PREPARATION OF A (2,3,4,4-TETRAMETHYLCYCLOPENTYL) METHYL CARBOXYLATE COMPOUND Shin-Etsu Chemical Co., Ltd. (JP) 2017-11-29 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170342013-A1 ALPHA-HALOTETRAMETHYCYCLOHEXANONE, A METHOD FOR THE PREPARATION THEREOF, AND A METHOD FOR THE PREPARATION OF A (2,3,4,4-TETRAMETHYLCYCLOPENTYL)METHY CARBOXYLATE COMPOUND PTMS, FOSB, PTMA APLNR 3273/4885GRM4 2527/4885CYP2C19 2620/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.